Amedisys (AMED) Tops Q3 EPS by 18c, Raises FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amedisys Reports Third Quarter 2018 Financial Results and Updates 2018 Guidance
October 29, 2018 5:00 PM EDTBATON ROUGE, La., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month period ended September 30, 2018.
Three Month Periods Ended September 30, 2018 and 2017
Net service revenue increased $43.6Â million to $417.3Â million compared to $373.7Â million in 2017 (1).Net income attributable to Amedisys, Inc. of $31.4Â million compared to $14.6Â million in 2017.Net income attributable to Amedisys, Inc. per diluted share of $0.96 per diluted share compared to $0.42 in 2017.Adjusted Quarterly Results*
Adjusted EBITDA of $45.3Â million compared to $36.9Â million in 2017.Adjusted net service... More